Human intestinal microbiota: Characterization of a simplified and stable gnotobiotic rat model

Gut Microbes

Volumn 2, Issue 1, 2011, Pages 25-33

  Becker, Natalie ^a   Kunath, Julia ^a   Loh, Gunnar ^a   Blaut, Michael ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Dietary fibre; Gnotobiotic rats; High fat diet; Human intestinal microbiota; Simplified model

Indexed keywords

BETA ASPARTYLGLYCINE; BILIRUBIN; BUTYRIC ACID; GLYCINE DERIVATIVE; MUCIN; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG; BUTYRIC ACID DERIVATIVE; VOLATILE FATTY ACID;

ANAEROSTIPES CACCAE; ARTICLE; BACTEROIDES THETAIOTAOMICRON; BIFIDOBACTERIUM LONGUM; BLAUTIA PRODUCTA; CLOSTRIDIUM BUTYRICUM; CLOSTRIDIUM RAMOSUM; CONTROLLED STUDY; DIETARY FIBER; DIETARY INTAKE; ESCHERICHIA COLI; FAT CONTENT; GERMFREE ANIMAL; GNOTOBIOTICS; HUMAN; INTESTINE FLORA; LACTOBACILLUS PLANTARUM; LIPID DIET; MICROBIAL DEGRADATION; MOUSE; NONHUMAN; RAT; SIMPLIFIED HUMAN INTESTINAL MICROBIOTA; ANIMAL; ANIMAL MODEL; BACTERIUM; CHEMISTRY; CLASSIFICATION; EVALUATION; FAT INTAKE; FECES; FEMALE; GROWTH, DEVELOPMENT AND AGING; INTESTINE; MALE; METABOLISM; METAGENOME; MICROBIOLOGY; SPRAGUE DAWLEY RAT;

ANAEROSTIPES CACCAE; ANIMALIA; BACTERIA (MICROORGANISMS); BACTEROIDES THETAIOTAOMICRON; BIFIDOBACTERIUM LONGUM; CLOSTRIDIUM BUTYRICUM; CLOSTRIDIUM RAMOSUM; ESCHERICHIA COLI; LACTOBACILLUS PLANTARUM; MUS; RATTUS;

ANIMALS; BACTERIA; BUTYRATES; CLOSTRIDIUM BUTYRICUM; DIETARY FATS; DIETARY FIBER; FATTY ACIDS, VOLATILE; FECES; FEMALE; GERM-FREE LIFE; HUMANS; INTESTINES; MALE; METAGENOME; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79956224326     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.2.1.14651     Document Type: Article

References (42)

1. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science 2005; 308:1635-8.
2. Tap J, Mondot S, Levenez F, Pelletier E, Caron C, Furet JP, et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 2009; 11:2574-84.
3. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65.
4. Silvi S, Rumney CJ, Cresci A, Rowland IR. Resistant starch modifies gut microflora and microbial metabolism in human flora-associated rats inoculated with faeces from Italian and UK donors. J Appl Microbiol 1999; 86:521-30.
5. Sharma R, Young C, Neu J. Molecular modulation of intestinal epithelial barrier: contribution of microbiota. J Biomed Biotechnol 2010; 2010:305879.
6. Possemiers S, Bolca S, Eeckhaut E, Depypere H, Verstraete W. Metabolism of isoflavones, lignans and prenylflavonoids by intestinal bacteria: producer phenotyping and relation with intestinal community. FEMS Microbiol Ecol 2007; 61:372-83.
7. Falk PG, Hooper LV, Midtvedt T, Gordon JI. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev 1998; 62:1157-70.
8. Dewhirst FE, Chien CC, Paster BJ, Ericson RL, Orcutt RP, Schauer DB, et al. Phylogeny of the defined murine microbiota: altered Schaedler flora. Appl Environ Microbiol 1999; 65:3287-92.
9. Norin E, Midtvedt T. Intestinal microflora functions in laboratory mice claimed to harbor a "normal" intestinal microflora. Is the SPF concept running out of date? Anaerobe 2009; 16:311-3.
10. Midtvedt T, Bjorneklett A, Carlstedt-Duke B, Gustafsson BE, Hoverstad T, Lingaas E, et al. The influence of antibiotics upon microflora-associated characteristics in man and mammals. Prog Clin Biol Res 1985; 181:241-4.
11. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001; 81:1031-64.
12. Kruse HP, Kleessen B, Blaut M. Effects of inulin on fecal bifidobacteria in human subjects. Br J Nutr 1999; 82:375-82.
13. Kleessen B, Hartmann L, Blaut M. Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human fecal flora. Br J Nutr 2001; 86:291-300.
14. Fleissner CK, Huebel N, Abd El-Bary MM, Loh G, Klaus S, Blaut M. Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr 2010:1-11.
15. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102:11070-5.
16. Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2009; 18:190-5.
17. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010; 90:859-904.
18. Mahowald MA, Rey FE, Seedorf H, Turnbaugh PJ, Fulton RS, Wollam A, et al. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci USA 2009; 106:5859-64.
19. Denou E, Rezzonico E, Panoff JM, Arigoni F, Brussow H. A Mesocosm of Lactobacillus johnsonii, Bifidobacterium longum and Escherichia coli in the mouse gut. DNA Cell Biol 2009; 28:413-22.
20. Martin FP, Wang Y, Sprenger N, Yap IK, Lundstedt T, Lek P, et al. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol Syst Biol 2008; 4:157.
21. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007; 5:177.
22. Falony G, Vlachou A, Verbrugghe K, De Vuyst L. Crossfeeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Appl Environ Microbiol 2006; 72:7835-41.
23. van Tongeren SP, Slaets JP, Harmsen HJ, Welling GW. Fecal microbiota composition and frailty. Appl Environ Microbiol 2005; 71:6438-42.
24. Midtvedt T, Gustafsson BE. Microbial conversion of bilirubin to urobilins in vitro and in vivo. Acta Pathol Microbiol Scand B 1981; 89:57-60.
25. Henriksson A, Khaled AKD, Conway PL. The effect of caectomy on the fecal concentrations of urobilinogen and active trypsin in mice. Microbial Ecology in Health and Disease 1996; 9:61-5.
26. Midtvedt T, Carlstedt-Duke B, Hoverstad T, Midtvedt AC, Norin KE, Saxerholt H. Establishment of a biochemically active intestinal ecosystem in ex-germfree rats. Appl Environ Microbiol 1987; 53:2866-71.
27. Welling GW, Stege GJJ, Meijer-Severs GJ. ß-Aspartylpeptidase activity, a microflora associated characteristic (MAC); Its presence in different strains of anaerobic bacteria. Microb Ecol Health Dis 1988; 1:45-9.
28. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010; 107:14691-6.
29. Shinohara K, Ohashi Y, Kawasumi K, Terada A, Fujisawa T. Effect of apple intake on fecal microbiota and metabolites in humans. Anaerobe 2010; 16:510-5.
30. Sanz Y, Santacruz A, Gauffin P. Gut microbiota in obesity and metabolic disorders. Proc Nutr Soc 2010; 69:434-41.
31. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444:1022-3.
32. West SE, Wilkins TD. Vaspar broth-disk procedure for antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother 1980; 17:288-91.
33. Gniechwitz D, Brueckel B, Reichardt N, Blaut M, Steinhart H, Bunzel M. Coffee dietary fiber contents and structural characteristics as influenced by coffee type and technological and brewing procedures. J Agric Food Chem 2007; 55:11027-34.
34. Paetz A. Neue DIN 19738: 2000-05 (Entwurf): Bodenbeschaffenheit-Resorptionsverfügbarkeit von organischen und anorganischen Schadstoffen aus kontaminiertem Bodenmaterial. Umweltmed Forsch Prax 2000; 5:319-20.
35. Thiel R, Blaut M. An improved method for the automated enumeration of fluorescently labelled bacteria in human faeces. J Microbiol Methods 2005; 61:369-79.
36. Scheppach W, Sachs M, Bartram P, Kasper H. Fecal short-chain fatty acids after colonic surgery. Eur J Clin Nutr 1989; 43:21-5.
37. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
38. Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, et al. Differences in fecal microbiota in different European study populations in relation to age, gender and country: a cross-sectional study. Appl Environ Microbiol 2006; 72:1027-33.
39. Harmsen HJ, Raangs GC, He T, Degener JE, Welling GW. Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol 2002; 68:2982-90.
40. Fischer B, Hoh S, Wehler M, Hahn EG, Schneider HT. Fecal elastase-1: Lyophilization of stool samples prevents false low results in diarrhoea. Scand J Gastroenterol 2001; 36:771-4.
41. Moore WE, Holdeman LV. Human fecal flora: The normal flora of 20 Japanese-Hawaiians. Appl Microbiol 1974; 27:961-79.
42. Bartosch S, Fite A, Macfarlane GT, McMurdo ME. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 2004; 70:3575-81.